These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 17875709

  • 1. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
    Alves-Guerra MC, Ronchini C, Capobianco AJ.
    Cancer Res; 2007 Sep 15; 67(18):8690-8. PubMed ID: 17875709
    [Abstract] [Full Text] [Related]

  • 2. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE, Wang MX, Li RQ.
    Cancer Invest; 2009 Jul 15; 27(6):604-12. PubMed ID: 19440933
    [Abstract] [Full Text] [Related]

  • 3. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S, Bapat B.
    Oncogene; 2004 Oct 28; 23(50):8260-71. PubMed ID: 15377999
    [Abstract] [Full Text] [Related]

  • 4. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
    Tetsu O, McCormick F.
    Nature; 1999 Apr 01; 398(6726):422-6. PubMed ID: 10201372
    [Abstract] [Full Text] [Related]

  • 5. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.
    Feng Y, Bommer GT, Zhai Y, Akyol A, Hinoi T, Winer I, Lin HV, Cadigan KM, Cho KR, Fearon ER.
    Cancer Res; 2007 Jan 15; 67(2):482-91. PubMed ID: 17234755
    [Abstract] [Full Text] [Related]

  • 6. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
    Takahashi M, Nakamura Y, Obama K, Furukawa Y.
    Int J Oncol; 2005 Dec 15; 27(6):1483-7. PubMed ID: 16273202
    [Abstract] [Full Text] [Related]

  • 7. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
    Zhao DH, Hong JJ, Guo SY, Yang RL, Yuan J, Wen CY, Zhou KY, Li CJ.
    Cell Res; 2004 Feb 15; 14(1):74-80. PubMed ID: 15040893
    [Abstract] [Full Text] [Related]

  • 8. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K, Akcali KC, Ozturk M.
    Oncol Rep; 2006 Mar 15; 15(3):701-7. PubMed ID: 16465433
    [Abstract] [Full Text] [Related]

  • 9. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
    Shiina H, Igawa M, Breault J, Ribeiro-Filho L, Pookot D, Urakami S, Terashima M, Deguchi M, Yamanaka M, Shirai M, Kaneuchi M, Kane CJ, Dahiya R.
    Clin Cancer Res; 2003 Jun 15; 9(6):2121-32. PubMed ID: 12796377
    [Abstract] [Full Text] [Related]

  • 10. Physical and functional cooperation between AP-1 and beta-catenin for the regulation of TCF-dependent genes.
    Toualbi K, Güller MC, Mauriz JL, Labalette C, Buendia MA, Mauviel A, Bernuau D.
    Oncogene; 2007 May 24; 26(24):3492-502. PubMed ID: 17146436
    [Abstract] [Full Text] [Related]

  • 11. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
    González-Sancho JM, Aguilera O, García JM, Pendás-Franco N, Peña C, Cal S, García de Herreros A, Bonilla F, Muñoz A.
    Oncogene; 2005 Feb 03; 24(6):1098-103. PubMed ID: 15592505
    [Abstract] [Full Text] [Related]

  • 12. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
    Sasaki T, Suzuki H, Yagi K, Furuhashi M, Yao R, Susa S, Noda T, Arai Y, Miyazono K, Kato M.
    Cancer Res; 2003 Feb 15; 63(4):801-6. PubMed ID: 12591729
    [Abstract] [Full Text] [Related]

  • 13. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW, Lee SH, Yoon JW, Park WS, Choi KY, Min do S.
    Cancer Res; 2010 May 15; 70(10):4233-42. PubMed ID: 20442281
    [Abstract] [Full Text] [Related]

  • 14. Galectin-3, a novel binding partner of beta-catenin.
    Shimura T, Takenaka Y, Tsutsumi S, Hogan V, Kikuchi A, Raz A.
    Cancer Res; 2004 Sep 15; 64(18):6363-7. PubMed ID: 15374939
    [Abstract] [Full Text] [Related]

  • 15. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells.
    Chen RH, McCormick F.
    Cancer Res; 2001 Jun 01; 61(11):4445-9. PubMed ID: 11389074
    [Abstract] [Full Text] [Related]

  • 16. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
    Murakami T, Toda S, Fujimoto M, Ohtsuki M, Byers HR, Etoh T, Nakagawa H.
    Biochem Biophys Res Commun; 2001 Oct 19; 288(1):8-15. PubMed ID: 11594745
    [Abstract] [Full Text] [Related]

  • 17. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
    Renard CA, Labalette C, Armengol C, Cougot D, Wei Y, Cairo S, Pineau P, Neuveut C, de Reyniès A, Dejean A, Perret C, Buendia MA.
    Cancer Res; 2007 Feb 01; 67(3):901-10. PubMed ID: 17283120
    [Abstract] [Full Text] [Related]

  • 18. Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas.
    Fujita M, Furukawa Y, Tsunoda T, Tanaka T, Ogawa M, Nakamura Y.
    Cancer Res; 2001 Nov 01; 61(21):7722-6. PubMed ID: 11691783
    [Abstract] [Full Text] [Related]

  • 19. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
    Fuerer C, Homicsko K, Lukashev AN, Pittet AL, Iggo RD.
    BMC Cancer; 2006 Oct 04; 6():236. PubMed ID: 17020613
    [Abstract] [Full Text] [Related]

  • 20. SKI activates Wnt/beta-catenin signaling in human melanoma.
    Chen D, Xu W, Bales E, Colmenares C, Conacci-Sorrell M, Ishii S, Stavnezer E, Campisi J, Fisher DE, Ben-Ze'ev A, Medrano EE.
    Cancer Res; 2003 Oct 15; 63(20):6626-34. PubMed ID: 14583455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.